These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3925068)

  • 21. Immunosuppressive T-cell antibody induction for heart transplant recipients.
    Penninga L; Møller CH; Gustafsson F; Gluud C; Steinbrüchel DA
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008842. PubMed ID: 24297433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recipient pretreatment with mammalian IL-10 prolongs mouse cardiac allograft survival by inhibition of anti-donor T cell responses.
    Li W; Fu F; Lu L; Narula SK; Fung JJ; Thomson AW; Qian S
    Transplant Proc; 1999; 31(1-2):115. PubMed ID: 10083035
    [No Abstract]   [Full Text] [Related]  

  • 23. Anti-CD2 receptor and anti-CD2 ligand (CD48) antibodies synergize to prolong allograft survival.
    Qin L; Chavin KD; Lin J; Yagita H; Bromberg JS
    J Exp Med; 1994 Jan; 179(1):341-6. PubMed ID: 7903681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pretreatment with cyclosporine and anti-interleukin 2 receptor antibody abrogates the anti-idiotype response in rat recipients of cardiac allografts.
    Tanaka K; Tilney NL; Stunkel KG; Hancock WW; Diamantstein T; Kupiec-Weglinski JW
    Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7375-9. PubMed ID: 2217171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-CD25 monoclonal antibody modulates cytokine expression and prolongs allografts survival in rats cardiac transplantation.
    Xia J; Jiang X; Huang Y; Zhang K; Xiao S; Yang C
    Chin Med J (Engl); 2003 Mar; 116(3):432-5. PubMed ID: 12781053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined anti-CD2 and anti-CD3 receptor monoclonal antibodies induce donor-specific tolerance in a cardiac transplant model.
    Chavin KD; Qin L; Lin J; Yagita H; Bromberg JS
    J Immunol; 1993 Dec; 151(12):7249-59. PubMed ID: 7903105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-2 receptor blockade in cardiac transplantation: influence of HLA-DR locus incompatibility on treatment efficacy.
    Lietz K; John R; Beniaminovitz A; Burke EM; Suciu-Foca N; Mancini DM; Edwards NM; Itescu S
    Transplantation; 2003 Mar; 75(6):781-7. PubMed ID: 12660501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism of action of anti-IL-2R monoclonal antibodies. ART-18 prolongs cardiac allograft survival in rats by elimination of IL-2R+ mononuclear cells.
    Tanaka K; Hancock WW; Osawa H; Stunkel KG; Alberghini TV; Diamantstein T; Tilney NL; Kupiec-Weglinski JW
    J Immunol; 1989 Nov; 143(9):2873-9. PubMed ID: 2530281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prolongation of primate renal allograft survival by anti-Tac, an anti-human IL-2 receptor monoclonal antibody.
    Reed MH; Shapiro ME; Strom TB; Milford EL; Carpenter CB; Weinberg DS; Reimann KA; Letvin NL; Waldmann TA; Kirkman RL
    Transplantation; 1989 Jan; 47(1):55-9. PubMed ID: 2643232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blockade of NKG2D synergized with CTLA4-Ig in promoting long-term graft survival in murine models of cardiac transplantation.
    Li J; Zhu H; Wang S; Ye P; Liu C; Wu J; Xia J
    Transplantation; 2012 Feb; 93(4):356-63. PubMed ID: 22179404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunologic characterization of murine cardiac allograft recipients with long-term graft survival due to anti-VCAM-1 or anti-CD4 monoclonal antibody therapy.
    Orosz CG; Bergese SD; Huang EH; Vanbuskirk AM
    Transplant Proc; 1995 Feb; 27(1):387-8. PubMed ID: 7533414
    [No Abstract]   [Full Text] [Related]  

  • 32. Positive effects of anti-T-cell monoclonal antibodies on rat allograft survival.
    Claesson K; Larsson P; Holmdahl R; Klareskog L; Forsum U; Tufveson G
    Transplant Proc; 1987 Feb; 19(1 Pt 1):615-6. PubMed ID: 3079163
    [No Abstract]   [Full Text] [Related]  

  • 33. Differential immunosuppressive activity of monoclonal CD2 antibodies on allograft rejection versus specific antibody production.
    Sido B; Dengler TJ; Otto G; Zimmermann R; Müller P; Meuer SC
    Eur J Immunol; 1998 Apr; 28(4):1347-57. PubMed ID: 9565375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-interleukin-2 receptor (IL-2R) antibody against rejection of organ grafts.
    Kupiec-Weglinski JW; Padberg W; Uhteg LC; Towpik E; Lord RH; Ma L; Diamantstein T; Strom TB; Tilney NL
    Transplant Proc; 1987 Feb; 19(1 Pt 1):591-3. PubMed ID: 2978926
    [No Abstract]   [Full Text] [Related]  

  • 35. Anti-CD2 monoclonal antibodies synergize with anti-CD3 to prolong allograft survival and decrease cytokine production.
    Chavin KD; Qin L; Lin J; Kaplan AJ; Bromberg JS
    Transplant Proc; 1993 Feb; 25(1 Pt 1):823-4. PubMed ID: 8094913
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunosuppressive antibody treatment prolongs graft survival in two murine models of segmental pancreas transplantation.
    Purcell LJ; Mottram PL; Mandel TE
    Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():349-52. PubMed ID: 8225401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitory effects of anti-interleukin 2 receptor and anti-L3T4 antibodies on delayed type hypersensitivity: the role of complement and epitope.
    Kelley VE; Gaulton GN; Strom TB
    J Immunol; 1987 May; 138(9):2771-5. PubMed ID: 3106488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pretreatment with cyclosporin A (CyA) and anti-interleukin 2 receptor monoclonal antibody (IL-2R MAb) abrogates the anti-idiotype response in rat recipients of cardiac allografts.
    Tanaka K; Kupiec-Weglinski JW; Hancock WW; Stunkel K; Diamantstein T; Tilney NL
    Transplant Proc; 1991 Feb; 23(1 Pt 1):281-2. PubMed ID: 1990532
    [No Abstract]   [Full Text] [Related]  

  • 39. Trichinella spiralis infection changes immune response in mice performed abdominal heterotopic cardiac transplantation and prolongs cardiac allograft survival time.
    Deng G; Deng R; Yao J; Liao B; Chen Y; Wu Z; Hu H; Zhou X; Ma Y
    Parasitol Res; 2016 Jan; 115(1):407-14. PubMed ID: 26481486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Negative and positive co-signaling with anti-BTLA (PJ196) and CTLA4Ig prolongs islet allograft survival.
    Truong W; Plester JC; Hancock WW; Kaye J; Merani S; Murphy KM; Murphy TL; Anderson CC; Shapiro AM
    Transplantation; 2007 Nov; 84(10):1368-72. PubMed ID: 18049125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.